Equities researchers at Oppenheimer assumed coverage on shares of CME Group (NASDAQ:CME) in a research report issued on Monday, The Fly reports. The brokerage set an “outperform” rating and a $234.00 price target on the financial services provider’s stock. Oppenheimer’s price objective points to a potential upside of 13.04% from the stock’s previous close.
A number of other equities research analysts have also commented on the company. UBS Group raised their price objective on CME Group from $191.00 to $214.00 and gave the stock a “neutral” rating in a research report on Thursday, September 5th. Barclays raised their price objective on CME Group from $191.00 to $197.00 and gave the stock an “overweight” rating in a research report on Thursday, May 23rd. Zacks Investment Research lowered CME Group from a “hold” rating to a “sell” rating and set a $158.00 price objective for the company. in a research report on Monday, May 27th. Deutsche Bank raised their price objective on CME Group from $224.00 to $240.00 and gave the stock a “buy” rating in a research report on Friday, August 9th. Finally, Wells Fargo & Co raised their price objective on CME Group from $176.00 to $200.00 and gave the stock a “market perform” rating in a research report on Wednesday, July 3rd. Three analysts have rated the stock with a sell rating, six have issued a hold rating and eight have issued a buy rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus price target of $199.50.
Shares of NASDAQ:CME traded up $1.20 during midday trading on Monday, reaching $207.00. The company had a trading volume of 1,120,444 shares, compared to its average volume of 1,569,032. The company has a debt-to-equity ratio of 0.15, a quick ratio of 1.05 and a current ratio of 1.05. CME Group has a 1-year low of $161.05 and a 1-year high of $224.91. The firm has a market cap of $74.56 billion, a price-to-earnings ratio of 30.35, a price-to-earnings-growth ratio of 4.57 and a beta of 0.19. The company has a fifty day simple moving average of $211.50 and a two-hundred day simple moving average of $191.58.
In other news, insider Sean Tully sold 7,200 shares of the firm’s stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $223.13, for a total transaction of $1,606,536.00. Following the completion of the sale, the insider now directly owns 19,923 shares of the company’s stock, valued at approximately $4,445,418.99. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Terrence A. Duffy sold 35,000 shares of the firm’s stock in a transaction dated Thursday, August 1st. The stock was sold at an average price of $200.15, for a total value of $7,005,250.00. Following the sale, the chief executive officer now directly owns 79,057 shares of the company’s stock, valued at $15,823,258.55. The disclosure for this sale can be found here. Insiders have sold a total of 59,626 shares of company stock valued at $12,255,934 over the last ninety days. Company insiders own 1.20% of the company’s stock.
Institutional investors and hedge funds have recently bought and sold shares of the company. Advantage Investment Management LLC raised its stake in shares of CME Group by 119.0% in the 2nd quarter. Advantage Investment Management LLC now owns 184 shares of the financial services provider’s stock valued at $36,000 after acquiring an additional 100 shares in the last quarter. Westside Investment Management Inc. bought a new position in shares of CME Group in the 2nd quarter valued at approximately $38,000. Close Asset Management Ltd bought a new position in shares of CME Group in the 1st quarter valued at approximately $34,000. Private Capital Group LLC raised its stake in shares of CME Group by 44.9% in the 2nd quarter. Private Capital Group LLC now owns 242 shares of the financial services provider’s stock valued at $40,000 after acquiring an additional 75 shares in the last quarter. Finally, Permanens Capital L.P. bought a new position in shares of CME Group in the 1st quarter valued at approximately $41,000. 84.85% of the stock is owned by institutional investors.
CME Group Company Profile
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.
Featured Story: Is it Safe to Invest in Commodities?
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.